Clinical Trials Sponsored by CaridianBCT Biotechnologies

Total 166 results

Taiga Biotechnologies, Inc.

Not yet recruiting

Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis

Myelofibrosis | Acute Myelogenous Leukemia

Italy, Croatia
Frontier Biotechnologies Inc.

Recruiting

Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects (ABL)

HIV-1-infection

United States
Taiga Biotechnologies, Inc.

Not yet recruiting

Safety and Early Efficacy Study of TBX-1400 in Patients With Severe Combined Immunodeficiency

Severe Combined Immunodeficiency

Israel
Adverum Biotechnologies, Inc.

Completed

ADVM-022 Intravitreal Gene Therapy for DME (INFINITY)

Diabetic Retinopathy | Diabetic Macular Edema

United States, Puerto Rico
ILiAD Biotechnologies
PPD

Completed

Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults

Pertussis | Whooping Cough

United States
Frontier Biotechnologies Inc.

Completed

A Study of FB2001 for Inhalation in Healthy Chinese Adults

COVID-19 Pandemic

China
Frontier Biotechnologies Inc.

Completed

Study to Evaluate Pharmacokinetic and Safety of Albuvirtide Between Intravenous Drip and Intravenous Injection

HIV/AIDS

China
Adaptive Biotechnologies
Covance

Completed

ImmuneSense™ COVID-19 Study

SARS-CoV-2 Infection | Coronavirus Disease (COVID-19)

United States
Adaptive Biotechnologies
Covance

Completed

ImmuneRACE - Immune Response Action to COVID-19 Events

Covid19

United States
Frontier Biotechnologies Inc.

Completed

Test Albuvirtide in Experienced Patients (TALENT)

HIV Infections | AIDS

China
Sentien Biotechnologies, Inc.

Active, not recruiting

A Study of Cell Therapy for Subjects With Acute Kidney Injury Who Are Receiving Continuous Renal Replacement Therapy

Acute Kidney Injury

United States
Adverum Biotechnologies, Inc.
Adverum Biotechnologies SAS, a wholly owned subsidiary of Adverum Biotechnologies...

Completed

A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)

Friedreich's Ataxia

France
IMBiotechnologies Ltd.

Completed

Safety and Efficacy of OCL 503 in Prostate Artery Embolization

Benign Prostatic Hyperplasia | Benign Prostatic Hypertrophy

Canada
IMBiotechnologies Ltd.

Completed

OCL 500 Treatment of Women With Symptomatic Uterine Fibroids

Myoma | Uterine Fibroid | Leiomyoma

Canada
ProtAffin Biotechnologie AG

Terminated

A Phase 1, First in Human Study to Investigate the Safety and Tolerability of PA401

Healthy Volunteers

United Kingdom
Adverum Biotechnologies, Inc.
Parexel

Active, not recruiting

Safety and Efficacy of ADVM-022 in Treatment-Experienced Patients With Neovascular Age-related Macular Degeneration [LUNA]

Neovascular Age-related Macular Degeneration

United States, France, United Kingdom
Nuwacell Biotechnologies Co., Ltd.

Not yet recruiting

A Trial to Evaluate the Safety and Preliminary Efficacy of iNK in the Treatment of Subjects With Solid Tumor

Solid Tumor
IMBiotechnologies Ltd.

Completed

Safety and Effectiveness of OCL 503 in the Treatment of Women With Leiomyomata

Leiomyomata

United States
Adaptive Biotechnologies
Stanford University

Recruiting

Optimizing ctDNA-based MRD Assessment in DLBCL, MCL, and FL Patients Undergoing CAR Therapy

Follicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma

United States
Adaptive Biotechnologies
Iqvia Pty Ltd

Completed

ImmuneSense Lyme Study

Lyme Disease

United States
Philogen S.p.A.
Immatics Biotechnologies GmbH

Terminated

F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma

Merkel Cell Carcinoma

Germany, Austria, Denmark, France, Spain, United Kingdom
Zhuhai Yufan Biotechnologies Co., Ltd

Recruiting

A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor | Advanced Solid Malignancies

China
Zhuhai Yufan Biotechnologies Co., Ltd

Recruiting

A Phase I Study, Evaluating the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects With Advanced Solid Tumors

Advanced Solid Tumor | Advanced Solid Malignancies

United States
Ology Bioservices
Enabling Biotechnologies (EB)

Completed

Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19

SARS-CoV-2

United States
Thallion Pharmaceuticals
LFB Biotechnologies, SAS

Completed

Study of Chimeric Monoclonal Antibodies to Shiga Toxins 1 and 2

Shiga Toxin Producing Bacterial Infection

Argentina, Peru, Chile
Ology Bioservices
Enabling Biotechnologies (EB)

Not yet recruiting

Study to Evaluate the Safety and Efficacy of a Monoclonal Antibody Cocktail for the Prevention of COVID-19

COVID-19

Mali, Mexico
Kevin Bruce

Not yet recruiting

Developing Protocols for Modelling of Genetic Diseases Using Induced Pluripotent Stem Cells

Genetic Disease
Immatics Biotechnologies GmbH
Bristol-Myers Squibb

Recruiting

IMA401 TCER® in Recurrent and/or Refractory Solid Tumors

Cancer | Solid Tumor, Adult | Refractory Cancer | Recurrent Cancer

Germany
Throne Biotechnologies Inc.
Chinese government fundings

Unknown

Stem Cell Educator Therapy in Type 1 Diabetes

Type 1 Diabetes

China, Spain
Cancer Research UK
Immatics Biotechnologies GmbH

Completed

Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United Kingdom
Throne Biotechnologies Inc.
Hackensack Meridian Health

Recruiting

Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes

Type 1 Diabetes

United States
Jennewein Biotechnologie GmbH
Analyze & Realize

Completed

Study Evaluating Growth and Tolerance of Infant Formula Containing HMOs

Infant Nutrition

Italy, Germany, Spain
Memorial Sloan Kettering Cancer Center
Adaptive Biotechnologies

Recruiting

Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)

United States
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Efficacy and Safety Study of I10E in Treatment of Patients With CIDP (PRISM)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Spain, United Kingdom, Italy, France, Tunisia, Turkey
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Fibrinogen in Haemorrhage of Delivery (FIDEL)

Post-Partum Hemorrhage

France, Martinique
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Pharmacokinetics and Safety of Roledumab in RhD-negative Pregnant Women Carrying an RhD-positive Foetus

Rh Disease

France
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Willebrand International Non-interventional Global Surveillance

Von Willebrand Disease

Norway, Germany, Italy, Belgium, Czechia, Finland, Greece
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Human Fibrinogen Concentrate (FGTW) in Pediatric Patients With Congenital Fibrinogen Deficiency

Hypofibrinogenemia, Congenital | Afibrinogenemia, Congenital

France, Lebanon, Morocco, Turkey
Nuwacell Biotechnologies Co., Ltd.
Beijing Friendship Hospital

Not yet recruiting

A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation

Acute Myeloid Leukemia
Laboratoire français de Fractionnement et de Biotechnologies

Recruiting

Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®

Hemophilia

United States
Memorial Sloan Kettering Cancer Center
Illuminare Biotechnologies

Recruiting

Fluorescent Imaging of Nerves With Illuminare-1 During Surgery

Prostate Adenocarcinoma

United States
Immatics Biotechnologies GmbH
National Cancer Institute (NCI)

Terminated

Peptide-based Glioma Vaccine IMA950 in Patients With Glioblastoma

Glioblastoma

United States
Laboratoire français de Fractionnement et de Biotechnologies

Completed

LFB-R603 Dose Finding in Patients With Advanced Stage B-Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

France
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Early Albumin Resuscitation During Septic Shock

Septic Shock

France
Laboratoire français de Fractionnement et de Biotechnologies

Recruiting

A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM (SCOPE HIM)

Hemophilia

United States, Thailand, Mexico, Turkey, South Africa, Malaysia
Laboratoire français de Fractionnement et de Biotechnologies

Completed

Safety Study of Alfalastin (Human Alpha-1 Antitrypsin) Administered at Home

Alpha 1-Antitrypsin Deficiency
Laboratoire français de Fractionnement et de Biotechnologies

Terminated

Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302 (PRISM2)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Spain, Italy, France, Tunisia, United Kingdom, Turkey
Throne Biotechnologies Inc.
Chinese PLA General Hospital

Unknown

Stem Cell Educator Therapy in Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

China
Laboratoire français de Fractionnement et de Biotechnologies

No longer available

HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency (EAP)

Surgery | Postpartum Hemorrhage | Wound; Rupture, Surgery, Cesarean Section

United States
University of Calgary
IMBiotechnologies Ltd.

Not yet recruiting

Evaluate the Safety and Effectiveness of Using Echogenic Embolic Agent for Embolization of Prostate Artery for Treatment of Men With BPH (PAE CEUS) (PAE CEUS)

Benign Prostatic Hyperplasia

Clinical Trials Sponsored by CaridianBCT Biotechnologies

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations